Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
(2016) In The International Journal of Chronic Obstructive Pulmonary Disease 11. p.381-390- Abstract
- Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8853070
- author
- Calverley, Peter M ; Postma, Dirkje S ; Anzueto, Antonio R ; Make, Barry J ; Eriksson, Göran LU ; Peterson, Stefan and Jenkins, Christine R
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The International Journal of Chronic Obstructive Pulmonary Disease
- volume
- 11
- pages
- 381 - 390
- publisher
- Dove Medical Press Ltd.
- external identifiers
-
- pmid:26952309
- scopus:84959365536
- pmid:26952309
- wos:000370975600001
- ISSN
- 1178-2005
- DOI
- 10.2147/COPD.S93303
- language
- English
- LU publication?
- yes
- id
- a59be422-5676-41ae-adf6-82b459adc212 (old id 8853070)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26952309?dopt=Abstract
- date added to LUP
- 2016-04-01 11:14:11
- date last changed
- 2022-03-05 02:34:34
@article{a59be422-5676-41ae-adf6-82b459adc212, abstract = {{Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.}}, author = {{Calverley, Peter M and Postma, Dirkje S and Anzueto, Antonio R and Make, Barry J and Eriksson, Göran and Peterson, Stefan and Jenkins, Christine R}}, issn = {{1178-2005}}, language = {{eng}}, pages = {{381--390}}, publisher = {{Dove Medical Press Ltd.}}, series = {{The International Journal of Chronic Obstructive Pulmonary Disease}}, title = {{Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.}}, url = {{http://dx.doi.org/10.2147/COPD.S93303}}, doi = {{10.2147/COPD.S93303}}, volume = {{11}}, year = {{2016}}, }